CDK6 and neoplasm: In addition, the tumor suppressor miR-125a, which targets ERBB2 (erb-b2 receptor tyrosine kinase 2), and miR-129, which targets CDK6 (cyclin-dependent kinase 6), are also involved in anti-proliferative and pro-apoptotic functions [24,126,127,131].